Royal Philips Electronics has released the BiPAP autoSV Advanced, its latest device for treating complicated sleep-disordered breathing patients.
The system is designed to effectively manage challenging sleep apnea cases.
__________

Royal Philips Electronics has released the BiPAP autoSV Advanced, its latest device for treating complicated sleep-disordered breathing patients.
The system is designed to effectively manage challenging sleep apnea cases.
Royal Philips Electronics today showcased the next generation Philips Respironics Sleep Therapy System at Medtrade 2009, a conference and expo for the home medical equipment industry.
The arrival of the new product line brings advances in sleep apnea therapy, the manufacturer says, that will benefit millions of sleep apnea sufferers, as well as bring new solutions to healthcare providers trying to meet today’s healthcare challenges.
People with even minimally symptomatic obstructive sleep apnea (OSA) may be at increased risk for cardiovascular disease because of impaired endothelial function and increased arterial stiffness, according to a study in the November 2008 issue of American Journal of Respiratory and Critical Care Medicine.
Their findings suggested that minimally symptomatic OSA is a cardiovascular risk factor to a degree not previously known.
A study published in the Journal of Clinical Sleep Medicine suggests screening patients with Type 2 diabetes for obstructive sleep apnea (OSA) and treating those who have obstructive sleep apnea with xPAP therapy could improve the management of their hyperglycemia and might favorably influence their long-term prognosis.
According to Arthur Dawson, M.D., Scripps Clinic Sleep Center, it is not surprising that many diabetics have sleep apnea since Type 2 diabetes and obstructive sleep apnea are both conditions that are becoming much more common because of the obesity epidemic.
A Swedish study reveals that children who grow up in a large family or who are exposed to animals often have respiratory or ear infections in early life are more likely to develop into snorers in later life.
Snoring is not just a potential annoyance. In some cases, it can be a sign of a potentially fatal respiratory condition known as obstructive sleep apnea which causes a narrowing or collapse of the throat during sleep, and as a result, can increase the risk of heart disease and stroke, lead to memory loss, depression, diabetes, among other health issues.
A study published in the July 1, 2008, issue of the journal Sleep provides visual evidence of the severe structural damage that occurs in numerous regions of the brain in people with obstructive sleep apnea (OSA).
Results show that obstructive sleep apnea patients have extensive alterations in “white matter,” nerve tissue in the brain containing fibers that are insulated with myelin — a white, fatty sheath. These structural changes appear both in brain regions that have functional importance for characteristics such as mood, memory, and cardiovascular regulation; and in fiber pathways interconnecting these regions.
The Centers for Medicare & Medicaid Services (CMS) has expanded Medicare coverage for continuous positive airway pressure (CPAP) devices to include beneficiaries who have been diagnosed, using a home sleep test, with obstructive sleep apnea. CMS also announced changes to simplify certain test requirements.
Obstructive sleep apnea (OSA) is a condition characterized by the complete cessation of breathing for a period of at least 10 seconds (apnea) during sleep. In most instances, obstructive sleep apnea is diagnosed by counting the number of sleep disturbances that occur during a specific time interval. Up to four million Medicare beneficiaries may suffer from some form of obstructive sleep apnea.
The benefits of “healthy driving” programs keep piling up for carriers in terms of healthier, happier, safer and more productive drivers, and all of that can’t help but boost retention rates while improving the bottom line.
Consider the case of Schneider National, Inc., for example. Earlier this year, Schneider National received the 2007 National Sleep Foundation Healthy Sleep Community Award for creating a groundbreaking obstructive sleep apnea OSA detection and treatment program for its drivers.
As of May 2, 2009 at 9:47 p.m. (-0500) (ET), the U.S. population
was 306,340,710. Sleep researchers estimate approximately seven percent
of the population suffers from obstructive sleep apnea. Using that
estimate, there are potentially 21,443,850 apneics in the U.S.
~~ Apnea around the world ~~
As of May 2, 2009 at 9:47 p.m. (-0500) (ET), the world population
was 6,777,286,604. Sleep researchers estimate approximately seven percent
of the population suffers from obstructive sleep apnea. Using that
estimate, there are potentially 474,410,062 apneics in the world.